Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?
A:
The external domain of the receptor is designed to recognize specific molecular markers on a tumor cell and, when this happens, the internal signaling domain of the molecule is...
English
保存
共有
さらに表示
